Global Diagnostic Electrocardiograph Market

Diagnostic Electrocardiograph Market Size, Share, Growth Analysis, By Product(Devices (Resting ECG Devices, Stress ECG Devices, Holter Monitors, Event Monitors), By Lead Type(12-Lead ECG Devices, 5-Lead ECG Devices, 3-Lead ECG Devices, 6-Lead ECG Devices), By End User(Hospitals, Clinics, And Cardiac Centers, Ambulatory Surgery Centers), By Region - Industry Forecast 2024-2031

Report ID: SQMIG35A2621 | Region: Global | Published Date: October, 2024
Pages: 270 | Tables: 93 | Figures: 76

Diagnostic Electrocardiograph Market Competitive Landscape

The global diagnostic electrocardiograph (ECG) market is fairly fragmented in nature due to the presence of several key market players operating all around the globe. Major key players of the global market are shifting their focus on various business developing strategies like acquisitions, mergers, collaboration, new technology development, and rising R&D activities for the expansion of their geographical presence and product portfolio.

Diagnostic Electrocardiograph Market Top Player’s Company Profiles

  • General Electric 
  • Koninklijke Philips N.V. 
  • Baxter International Inc. 
  • Fukuda Denshi 
  • Mindray Medical International Limited 
  • Nihon Kohden Corporation 
  • OSI Systems, Inc. 
  • BPL Medical Technologies 
  • Schiller AG 
  • Bittium 
  • ACS Diagnostics 
  • Allengers Medical Systems Ltd. 
  • Bionet 
  • Cardiac Insight, Inc. 
  • BTL 
  • Meditech Equipment Co. Ltd. 
  • Midmark Corporation 
  • AliveCor, Inc. 
  • VitalConnect 
  • iRhythm Technologies, Inc. 
  • Borsam Biomedical Instruments Co., Ltd. 
  • Nasiff Associates, Inc. 
  • VectraCor 
  • Biomedical Instruments Co. Ltd. 
  • LifeSignals, Inc.

Diagnostic Electrocardiograph Market

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Global Diagnostic Electrocardiograph Market size was valued at USD 7.60 billion in 2022 and is poised to grow from USD 8.13 billion in 2023 to USD 13.89 billion by 2031, growing at a CAGR of 6.12% during the forecast period (2024-2031).

The global diagnostic electrocardiograph (ECG) market is fairly fragmented in nature due to the presence of several key market players operating all around the globe. Major key players of the global market are shifting their focus on various business developing strategies like acquisitions, mergers, collaboration, new technology development, and rising R&D activities for the expansion of their geographical presence and product portfolio. 'General Electric ', 'Koninklijke Philips N.V. ', 'Baxter International Inc. ', 'Fukuda Denshi ', 'Mindray Medical International Limited ', 'Nihon Kohden Corporation ', 'OSI Systems, Inc. ', 'BPL Medical Technologies ', 'Schiller AG ', 'Bittium ', 'ACS Diagnostics ', 'Allengers Medical Systems Ltd. ', 'Bionet ', 'Cardiac Insight, Inc. ', 'BTL ', 'Meditech Equipment Co. Ltd. ', 'Midmark Corporation ', 'AliveCor, Inc. ', 'VitalConnect ', 'iRhythm Technologies, Inc. ', 'Borsam Biomedical Instruments Co., Ltd. ', 'Nasiff Associates, Inc. ', 'VectraCor ', 'Biomedical Instruments Co. Ltd. ', 'LifeSignals, Inc.'

High growth in geriatric population along with an increasing risk for the development of various cardiovascular diseases and growing consumer awareness towards availability of several non-invasive techniques are key factors expected to drive the growth of the global diagnostic electrocardiograph (ECG) market during the forecast period.

A new and advanced generation of completely portable and compact Holter ECGs around the globe has been resulting the higher adoption of these devices, mainly in the home healthcare segment. The various advantages of the Holter ECGs and its high accessibility is creating lucrative growth opportunities for the global market. Furthermore, rising number of collaborations among manufacturer companies of the Holter ECGs is also contributing significantly to the growth of the market over the last few years.

Globally, North America dominated the diagnostic electrocardiograph market and accounted for a significant market share and is projected to maintain its dominance throughout the forecast period. Growing frequency of cardiovascular diseases and early adoption of advanced technologies are the key major factors expected to drive the growth of the market in the region. According to the American Heart Association, around 82.6 million Americans have one or more types of cardiovascular diseases, and nearly 659,000 Americans die from these diseases every year.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

Click here right-arrow
logo-images

Related Reports

Rapid Diagnostics Market
Buy Now GET FREE SAMPLE
Electrophysiology Market
Buy Now GET FREE SAMPLE
Cardiac Pacemaker Market
Buy Now GET FREE SAMPLE
Medical Electrodes Market
Buy Now GET FREE SAMPLE
Hemodynamic Monitoring Market
Buy Now GET FREE SAMPLE
Tissue Diagnostics Market
Buy Now GET FREE SAMPLE
Cardiac Monitoring and Cardiac Rhythm Management Devices Market
Buy Now GET FREE SAMPLE
Companion Diagnostics Market
Buy Now GET FREE SAMPLE

Feedback From Our Clients

Global Diagnostic Electrocardiograph Market

Report ID: SQMIG35A2621

$5,300
BUY NOW GET FREE SAMPLE